This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Messud-Petit, F.
Right arrow Articles by Bertagnoli, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Messud-Petit, F.
Right arrow Articles by Bertagnoli, S.

 Previous Article  |  Next Article 

Journal of Virology, October 1998, p. 7830-7839, Vol. 72, No. 10
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Serp2, an Inhibitor of the Interleukin-1beta -Converting Enzyme, Is Critical in the Pathobiology of Myxoma Virus

Frederique Messud-Petit,1 Jacqueline Gelfi,1 Maxence Delverdier,2 Marie-France Amardeilh,2 Robert Py,1 Gerd Sutter,3 and Stephane Bertagnoli1,*

Laboratoire Associe de Microbiologie Moleculaire1 and Laboratoire d'Anatomie Pathologique,2 Institut National de la Recherche Agronomique and Ecole Nationale Vétérinaire, Toulouse, France, and GSF-Institute of Molecular Virology, Oberscheissheim, Germany3

Received 9 March 1998/Accepted 2 July 1998

Recently, myxoma virus was shown to encode an additional member of the serpin superfamily. The viral gene, called serp2, was cloned, and the Serp2 protein was shown to specifically bind to interleukin-1beta (IL-1beta )-converting enzyme (ICE), thus inhibiting the cleavage of pro-IL-1beta by the protease (F. Petit, S. Bertagnoli, J. Gelfi, F. Fassy, C. Boucraut-Baralon, and A. Milon, J. Virol. 70:5860-5866, 1996). Here, we address the role of Serp2 in the development of myxomatosis, a lethal infectious disease of the European rabbit. A Serp2 mutant myxoma virus was constructed by disruption of the single-copy serp2 gene and insertion of the Escherichia coli gpt gene serving as the selectable marker. A revertant virus was obtained by replacing the E. coli gpt gene by the intact serp2 open reading frame. The Serp2- mutant virus replicated with wild-type kinetics both in rabbit fibroblasts and a rabbit CD4+ T-cell line (RL5). Moderate reduction of cell surface levels of major histocompatibility complex I was observed after infection with wild-type or Serp2- mutant myxoma virus, and both produced white pocks on the chorioallantoic membrane of the chick embryo. After the infection of European rabbits, the Serp2- mutant virus proved to be highly attenuated compared to wild-type myxoma virus, as demonstrated by the clinical course of myxomatosis and the survival rates of infected animals. Pathohistological examinations revealed that infection with wild-type myxoma virus resulted in a blockade of the inflammatory response at the vascular level. In contrast, rapid inflammatory reactions occurred upon infection with the Serp2- mutant virus. Furthermore, lymphocytes in lymph nodes derived from animals inoculated with Serp2 mutant virus were shown to rapidly undergo apoptosis. We postulate that the virulence of myxoma virus in the European rabbit can be partially attributed to an impairment of host inflammatory processes and to the prevention of apoptosis in lymphocytes. The weakening of host defense is directly linked to serp2 gene function and is likely to involve the inhibition of IL-1beta -converting-enzyme-dependent pathways.

* Corresponding author. Mailing address: Laboratoire Associe de Microbiologie Moleculaire, INRA-ENVT, Ecole Nationale Vétérinaire, 23 Chemin des Capelles, F-31076 Toulouse cedex 3, France. Phone: (33) 561-19-38-78. Fax: (33) 561-19-39-74. E-mail: s.bertagnoli{at}envt.fr.

Journal of Virology, October 1998, p. 7830-7839, Vol. 72, No. 10
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Sedger, L. M., Osvath, S. R., Xu, X.-M., Li, G., Chan, F. K.-M., Barrett, J. W., McFadden, G. (2006). Poxvirus Tumor Necrosis Factor Receptor (TNFR)-Like T2 Proteins Contain a Conserved Preligand Assembly Domain That Inhibits Cellular TNFR1-Induced Cell Death.. J. Virol. 80: 9300-9309 [Abstract] [Full Text]  
  • Sabourdy, F., Casteignau, A., Gelfi, J., Deceroi, S., Delverdier, M., Messud-Petit, F. L. (2004). Tumorigenic poxviruses: growth factors in a viral context?. J. Gen. Virol. 85: 3597-3606 [Abstract] [Full Text]  
  • Poncet, D., Larochette, N., Pauleau, A.-L., Boya, P., Jalil, A.-A., Cartron, P.-F., Vallette, F., Schnebelen, C., Bartle, L. M., Skaletskaya, A., Boutolleau, D., Martinou, J.-C., Goldmacher, V. S., Kroemer, G., Zamzami, N. (2004). An Anti-apoptotic Viral Protein That Recruits Bax to Mitochondria. J. Biol. Chem. 279: 22605-22614 [Abstract] [Full Text]  
  • Nathaniel, R., MacNeill, A. L., Wang, Y.-X., Turner, P. C., Moyer, R. W. (2004). Cowpox virus CrmA, Myxoma virus SERP2 and baculovirus P35 are not functionally interchangeable caspase inhibitors in poxvirus infections. J. Gen. Virol. 85: 1267-1278 [Abstract] [Full Text]  
  • Camus-Bouclainville, C., Fiette, L., Bouchiha, S., Pignolet, B., Counor, D., Filipe, C., Gelfi, J., Messud-Petit, F. (2004). A Virulence Factor of Myxoma Virus Colocalizes with NF-{kappa}B in the Nucleus and Interferes with Inflammation. J. Virol. 78: 2510-2516 [Abstract] [Full Text]  
  • Johnston, J. B., McFadden, G. (2003). Poxvirus Immunomodulatory Strategies: Current Perspectives. J. Virol. 77: 6093-6100 [Full Text]  
  • Hay, S., Kannourakis, G. (2002). A time to kill: viral manipulation of the cell death program. J. Gen. Virol. 83: 1547-1564 [Abstract] [Full Text]  
  • Guerin, J.-L., Gelfi, J., Boullier, S., Delverdier, M., Bellanger, F.-A., Bertagnoli, S., Drexler, I., Sutter, G., Messud-Petit, F. (2002). Myxoma Virus Leukemia-Associated Protein Is Responsible for Major Histocompatibility Complex Class I and Fas-CD95 Down-Regulation and Defines Scrapins, a New Group of Surface Cellular Receptor Abductor Proteins. J. Virol. 76: 2912-2923 [Abstract] [Full Text]  
  • Guerin, J.-L., Gelfi, J., Camus, C., Delverdier, M., Whisstock, J. C., Amardeihl, M.-F., Py, R., Bertagnoli, S., Messud-Petit, F. (2001). Characterization and functional analysis of Serp3: a novel myxoma virus-encoded serpin involved in virulence. J. Gen. Virol. 82: 1407-1417 [Abstract] [Full Text]  
  • Brick, D. J., Burke, R. D., Minkley, A. A., Upton, C. (2000). Ectromelia virus virulence factor p28 acts upstream of caspase-3 in response to UV light-induced apoptosis. J. Gen. Virol. 81: 1087-1097 [Abstract] [Full Text]  
  • Bárcena, J., Morales, M., Vázquez, B., Boga, J. A., Parra, F., Lucientes, J., Pagès-Manté, A., Sánchez-Vizcaíno, J. M., Blasco, R., Torres, J. M. (2000). Horizontal Transmissible Protection against Myxomatosis and Rabbit Hemorrhagic Disease by Using a Recombinant Myxoma Virus. J. Virol. 74: 1114-1123 [Abstract] [Full Text]  
  • Turner, P. C., Sancho, M. C., Thoennes, S. R., Caputo, A., Bleackley, R. C., Moyer, R. W. (1999). Myxoma Virus Serp2 Is a Weak Inhibitor of Granzyme B and Interleukin-1beta -Converting Enzyme In Vitro and Unlike CrmA Cannot Block Apoptosis in Cowpox Virus-Infected Cells. J. Virol. 73: 6394-6404 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»